C Surrenti
Overview
Explore the profile of C Surrenti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capanni M, Lorefice E, Benini M, Biagini M, Tozzi A, Salvadori E, et al.
J Chemother
. 2008 Jul;
20(3):380-4.
PMID: 18606596
Interferon therapy is indicated for the treatment of chronic hepatitis C and prevention of hepatocellular carcinoma. We describe the case of a 66-year-old Italian woman who received pegylated interferon alpha-2a...
2.
Orsini B, Vivas J, Ottanelli B, Amedei A, Surrenti E, Galli A, et al.
Int J Immunopathol Pharmacol
. 2008 Jan;
20(4):809-18.
PMID: 18179754
Recent evidence suggests that interleukin-4 (IL-4) is related to mucosal tolerance by which an injurious immune response is prevented, suppressed or shifted to a non-injurious response. We investigated the expression...
3.
Sofi F, Capalbo A, Marcucci R, Gori A, Fedi S, Macchi C, et al.
Eur J Clin Invest
. 2007 Nov;
37(12):947-53.
PMID: 17976196
Background: A large number of studies have demonstrated that regular physical activity during leisure time (LTPA) accounts for a significant protection against cardiovascular diseases (CVD). On the other hand, conflicting...
4.
Capanni M, Calella F, Biagini M, Genise S, Raimondi L, Bedogni G, et al.
Aliment Pharmacol Ther
. 2006 Apr;
23(8):1143-51.
PMID: 16611275
Background: Recent studies suggest a role of n-3 long-chain polyunsaturated fatty acids (n-3 PUFA) as peroxisome proliferator-activated receptor-alpha ligands in improving non-alcoholic fatty liver disease (NAFLD) in rodents. However, data...
5.
Surrenti C, Galli M
Minerva Gastroenterol Dietol
. 2006 Feb;
49(2):95-105.
PMID: 16481976
Alcoholic liver disease has a known etiology but a complex pathogenesis. The understanding of how alcohol damages the liver has expanded substantially over the last decade. In particular the genesis...
6.
Sofi F, Vecchio S, Giuliani G, Martinelli F, Marcucci R, Gori A, et al.
Eur J Clin Nutr
. 2005 Mar;
59(4):584-91.
PMID: 15741987
Objective: To evaluate dietary habits and lifestyle of Italian subjects, to provide current data on adequacy of the nutritional guidelines and recommendations especially in relation to primary prevention of cardiovascular...
7.
Galli A, Ceni E, Crabb D, Mello T, Salzano R, Grappone C, et al.
Gut
. 2004 Oct;
53(11):1688-97.
PMID: 15479693
Background/aims: Thiazolidinediones (TZD) are a new class of oral antidiabetic drugs that have been shown to inhibit growth of some epithelial cancer cells. Although TZD were found to be ligands...
8.
Orsini B, Nuti M, Ottanelli B, Ortolani M, Surrenti E, Milani S, et al.
Dig Liver Dis
. 2003 May;
35(2):127-8.
PMID: 12747632
No abstract available.
9.
Surrenti E, Ciancio G, Carloppi S, Lucchese M, Coppola A, Caramelli R, et al.
Dig Liver Dis
. 2003 Jan;
34(11):768-74.
PMID: 12546511
Background: Obese patients frequently present clinical symptoms related to gastrointestinal motility alterations and autonomic nervous system dysfunction. Aim: To evaluate the possible correlation between cardiovascular autonomic nervous dysfunction and oesophageal...
10.
Ciancio G, Nuti M, Orsini B, Iovi F, Ortolani M, Palomba A, et al.
Dig Liver Dis
. 2002 Apr;
34(1):16-21.
PMID: 11926569
Background: It is unclear whether the extent of duodenal gastric metaplasia is due to Helicobacter pylori and/or acid. Aims: To investigate the role of Helicobacter pylori eradication in the regression...